首页> 外文期刊>Neurobiology of Aging: Experimental and Clinical Research >Using next-generation sequencing as a genetic diagnostic tool in rare autosomal recessive neurologic Mendelian disorders
【24h】

Using next-generation sequencing as a genetic diagnostic tool in rare autosomal recessive neurologic Mendelian disorders

机译:使用新一代测序作为罕见的常染色体隐性遗传神经性孟德尔疾病的遗传诊断工具

获取原文
获取原文并翻译 | 示例
           

摘要

Next-generation sequencing was used to investigate 9 rare Chinese pedigrees with rare autosomal recessive neurologic Mendelian disorders. Five probands with ataxia-telangectasia and 1 proband with chorea-acanthocytosis were analyzed by targeted gene sequencing. Whole-exome sequencing was used to investigate 3 affected individuals with Joubert syndrome, nemaline myopathy, or spastic ataxia Charlevoix-Saguenay type. A list of known and novel candidate variants was identified for each causative gene. All variants were genetically verified by Sanger sequencing or quantitative polymerase chain reaction with the strategy of disease segregation in related pedigrees and healthy controls. The advantages of using next-generation sequencing to diagnose rare autosomal recessive neurologic Mendelian disorders characterized by genetic and phenotypic heterogeneity are demonstrated. A genetic diagnostic strategy combining the use of targeted gene sequencing and whole-exome sequencing with the aid of next-generation sequencing platforms has shown great promise for improving the diagnosis of neurologic Mendelian disorders.
机译:下一代测序用于研究9种罕见的常染色体隐性神经系统孟德尔疾病的中国谱系。通过靶向基因测序分析了五个共济失调性毛细血管扩张先证者和一个伴有嗜酸细胞吞噬作用的先证者。全外显子测序用于调查3名患有乔伯特综合征,肾母性肌病或痉挛性共济失调Charlevoix-Saguenay型的个体。为每个致病基因鉴定了一系列已知和新颖的候选变体。通过Sanger测序或定量聚合酶链反应对所有变体进行了遗传验证,并采用了相关谱系和健康对照中的疾病隔离策略。证明了使用下一代测序来诊断罕见的以遗传和表型异质性为特征的常染色体隐性隐性神经性孟德尔疾病的优势。遗传诊断策略结合了靶向基因测序和全外显子测序以及下一代测序平台的使用,已显示出改善神经孟德尔疾病诊断的巨大希望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号